Groundbreaking Partnership Aims to Revolutionize Sepsis Care through Real-Time Monitoring and Predictive Analytics
Hod Hasharon, Israel — February 2020 — ATLASense Biomed, a leader in advanced remote monitoring technology, is proud to announce that it has been awarded a grant by the Israeli Innovation Authority to develop further its innovative predictive analytics application for early sepsis screening. This grant highlights the Israeli Innovation Authority’s continued confidence in ATLASense’s vision and technology to make a global impact on patient outcomes.
In a pioneering collaboration with Prometheus, a company renowned for its advancements in healthcare technology, ATLASense Biomed aims to create an unprecedented solution for early sepsis screening. The joint effort will leverage ATLASense’s expertise in real-time physiological monitoring and Prometheus’s cutting-edge technology, providing clinicians with powerful, data-driven insights to detect sepsis at its earliest stages and prevent patient deterioration.
“We are honored to receive this grant and the continued support from the Israeli Innovation Authority,” said Tal Or, CEO of ATLASense Biomed. “This partnership with Prometheus is more than a collaboration; it’s a shared commitment to transform sepsis care through innovative technology. By combining our strengths, we aim to redefine how clinicians can identify and manage sepsis, ultimately saving lives and improving the quality of care worldwide.”
Sepsis is one of the most dangerous and costly healthcare challenges globally, claiming millions of lives each year. The ability to detect sepsis in its early stages is critical, as timely intervention significantly improves patient outcomes and reduces healthcare costs. Through this collaboration, ATLASense and Prometheus aim to provide healthcare providers with an advanced solution that integrates real-time monitoring with predictive analytics, alerting clinicians to early signs of sepsis before patients reach critical conditions.
About ATLASense Biomed
ATLASense Biomed is a leading healthcare technology company dedicated to developing advanced remote monitoring solutions. With a focus on real-time, predictive analytics, ATLASense’s wearable technology is designed to enhance patient care, prevent complications, and improve outcomes in a wide range of clinical applications.
www.atlasensebiomed.com
About Prometheus
Prometheus is a trailblazer in healthcare technology, focused on creating innovative solutions to improve patient care and health outcomes. Through advanced data analytics and groundbreaking technology, Prometheus is redefining how medical professionals can leverage data for better clinical decision-making.
For media inquiries, please contact:
Tal Or
Co-founder & CEO
ATLASense Biomed
+972-54-770-6688
Tal.or@atlasensebiomed.com